DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Escudier B. et al.
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
Lancet 2007;
370: 2103-2111
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.